Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Post by josameyeron Aug 11, 2012 3:19pm

498 Views

Post# 20207693

Brigus and Cash

I believe that on August 31 2012, 4.5 million is due by New West Capital for The Calais notes.What is still receiveable from Can Gold for Their interest obtained in The Ixhutan property in Mexico. What is still outstanding by Everton, for their interest obtained in Pueblo Yiejoii, Poton and Gueva to Brigus Gold.How many shares does Brigus Gold hold now in the aforementioned Namely Can Gold and Everton. What is the exercise price for the latest rights given to the insiders.Looking forward to the conference on Monday. Brigus the time has come to move up in a major way. Please DYODD. As always cheers Josa.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features